
Kerala Ayurveda Ltd. Approves Private Placement of Non-Convertible Debentures
Kerala Ayurveda Ltd. announced on March 25, 2026, that its Board of Directors approved the issuance of 4,000 Series 'A' unlisted, secured, and redeemable Non-Convertible Debentures (NCDs). Each NCD has a face value of Rs. 1,00,000, totaling an aggregate amount of Rs. 40,00,00,000. The issuance will occur on a private placement basis.The borrowing is within limits previously approved by the company's shareholders on August 22, 2025. The Board meeting commenced at 11:00 am and concluded at 12:10 pm.
Key details of the NCD issuance are outlined below:
| Particulars | Disclosures | |
|---|---|---|
| 1 | Type of securities | Series 'A' unlisted, secured and redeemable Non-Convertible Debentures |
| 2 | Type of issuance | Private placement |
| 3 | Total Number of Securities and aggregate amount | 4,000 NCDs with an aggregate amount of Rs. 40,00,00,000 |
| 4 | Size of the Issue | Rs. 40,00,00,000 |
| 5 | Listing Status | Not listed |
| 6 | Tenure of the instrument | Upto 10 years |
| 7 | Allotment and Maturity Dates | Allotment within 1 month; maturity after a moratorium of 24 months (2 years) followed by 32 quarterly instalments. |
| 8 | Coupon/Interest Rate | 12% p.a. on reducing balance year to year. |
| 9 | Payment Schedule | Quarterly interest payments; principal through a moratorium of 24 months (2 years) followed by 32 quarterly instalments. |
| 10 | Charge/Security | First Charge on Industrial Property (Factory Land & Building and Plant & Machinery) located at Kerala Ayurveda Ltd., Survey No. 264/1, 264/26, 264/27, Near St. Francis Assisi Church, Airport Road, Nedumbassery, Village Chengamanad, Taluka Aluva, Dist - Ernakulam, Kerala - 683585. |
| 11 | Special Rights/Privileges | Not Applicable |
| 12 | Default Penalties | 2% |
| 13 | Comments on Payment/Non-Payment | Nil |
| 14 | Redemption Details | Moratorium of 24 months (2 years) followed by 32 quarterly instalments. |
| 15 | Cancellation/Termination | Not Applicable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.